Can We Use ‘Personalized’ medicine to Prevent T1D
Dr. Haller presentation of “Can We Use ‘Personalized’ medicine to Prevent T1D?” at Columbia University / Naomi Berrie Center for Diabetes…
Dr. Haller presentation of “Can We Use ‘Personalized’ medicine to Prevent T1D?” at Columbia University / Naomi Berrie Center for Diabetes…
Dr. Michael Haller, professor and chief of pediatric endocrinology at UF, said his department switched almost completely to telemedicine for a while in March and April. Haller said his unit has created equipment packages for parents to perform telehealth physicals for their children, and wireless enabled iPads have also been…
While the pandemic has made some connections more difficult, access to telehealth services has increased for transgender patients, said Dr. Kristin Dayton, co-director of the University of Florida Health Youth Gender Program.
The initiative has collected $50,000 since its founding, largely supporting the research of Jennifer Miller, MD, a clinician and UF professor of pediatric endocrinology. Her research includes looking for effective support measures for people with PWS.
For children with diabetes or other endocrine system disorders who come from less affluent families, access to care can be difficult and time-consuming. University of Florida Health experts will provide services for children in underserved communities in Collier County through a new grant from the Naples Children & Education Foundation that…
As the start of the new school year quickly approaches in the United States, parents of children with diabetes are trying to figure out how their child’s needs will be met when classes begin.
If your child has type 1 diabetes, you know the importance of monitoring their blood sugar levels throughout the day, because occasionally, those glucose levels can swing too far up or down. When your child is at school, though, you may need to rely on teachers, school nurses, and…
Soleno Therapeutics has unveiled new data showing that its diazoxide choline controlled release (DCCR) tablets failed to reduce hyperphagia – or an abnormal desire for food – in patients with Prader-Willi syndrome.
Prader-Willi syndrome, a neurodevelopmental disorder that occurs in about 1 in 15,000 births, is the most common genetic cause of life-threatening childhood obesity, which is just one of its complex symptoms. …
Dear Patients and Families, On behalf of the University of Florida Pediatric Endocrine team I would like to update you on the current COVID-19 situation. First and foremost, please know that our team is available for you and your child during this public health emergency. Second, I want to…